Skip to main content
. 2016 Jun 14;7(29):45562–45574. doi: 10.18632/oncotarget.10037

Figure 3. CHMFL-074's anti-colony formation effects against intact cancer cell lines and anti-proliferative effect against CML patient primary cells.

Figure 3

(A) CHMFL-074's anti-colony formation effect against K562, KU812 and MEG-01 cells. (B) CHMFL-074's anti-proliferative effect against BCR-ABL positive CML patient primary cells and (C) normal white cells purified from the peripheral blood.